JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, cilt.72, sa.3, ss.906-913, 2017 (SCI-Expanded)
Background. Bloodstream infections (BSIs) due to ESBL-producing Enterobacteriaceae (ESBL-E) are frequent yet outcome prediction rules for clinical use have not been developed. The objective was to define and validate a predictive risk score for 30 day mortality.